Japan approves first domestically developed COVID-19 XBB vaccine – The Japan Times

Japans health ministry on Tuesday approved the first domestically developed COVID-19 vaccine that works against the currently circulating XBB.1.5 sublineage of the omicron variant.

The XBB-adapted version of Daiichi-Sankyos coronavirus vaccine, Daichirona, will be available as a booster under the nations free COVID-19 vaccination program beginning next week.

The government has already decided to procure a total of 1.4 million doses of the vaccine from the drugmaker, the first Japanese firm to have developed COVID-19 shots.

Read more:

Japan approves first domestically developed COVID-19 XBB vaccine - The Japan Times

Related Posts
Tags: